G1 Therapeutics, Inc. announced the grant of inducement stock options exercisable for an aggregate of 63,500 shares of G1’s common stock and an aggregate of 38,000 restricted stock units to six hired employees under the Amended and Restated G1 Therapeutics, Inc. 2021 Inducement Equity Incentive Plan.
